Hormonal and intrauterine contraception for women aged 40 years and older
Other
OA: gold
CC0
AI-generated summary
This editorial reviews hormonal and intrauterine contraception use in women over 40, addressing safety, effectiveness, noncontraceptive benefits, and counseling considerations for this age group.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The use of the levonorgestrel intrauterine device effectively treats heavy menstrual bleeding even when associated with adenomyosis or leiomyomas and is as effective as endometrial ablation in reducing heavy menstrual bleeding. This informational editorial answers the questions: Is contraception needed for women aged 40 years and older who do not desire to be pregnant? What are women aged 40 years and older using for contraception? Is contraceptive use in women aged 40 years or older riskier? What are the noncontraceptive benefits of contraception for women of this age group? Can women safely use contraception until the age of menopause? How should clinicians counsel this cohort of women about contraceptive use?
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis 2010
- Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomized, prospective, controlled clinical trial in female smokers 2008
- Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study 2010
References (19)
- Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis via openalex
- Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomized, prospective, controlled clinical trial in female smokers via openalex
- Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study via openalex
- W1627728252 via openalex
- W1981364761 via openalex
- W2001333713 via openalex
- W2017744150 via openalex
- W2027006764 via openalex
- W2048720185 via openalex
- W2052339405 via openalex
- W2059788501 via openalex
- W2122953592 via openalex
- W2143793800 via openalex
- W2164024255 via openalex
- W2415024591 via openalex
- W4238324662 via openalex
- W4240162768 via openalex
- W1521030336 via openalex
- W1584327144 via openalex
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-10-08T21:12:29.265612+00:00
License: CC0
· commercial use OK